R. Schleyerbach

Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat

Robert Bartlett, R. Schleyerbach · International Journal of Immunopharmacology · 1985 · 131 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation

Petya Dimitrova, Alla Skapenko, Matthias Herrmann et al. · The Journal of Immunology · 2002 · 86 citations · Full text

Immunomodulation of proteoglycan-induced progressive polyarthritis by lefluflomide

Tibor T. Giant, Katalin Mikecz, Robert Bartlett et al. · Immunopharmacology · 1992 · 44 citations

Inflammation, Rheumatology, Rheumatoid Disorder +8

Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation

D. Seiffge, T. Bissinger, E. Kremer et al. · Inflammation Research · 1995 · 26 citations

Inflammation, Inhibitory Effects, Antibiotics +10

Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis

H. U. Schorlemmer, R. Kurrle, R. Schleyerbach et al. · Inflammation Research · 1999 · 14 citations

Rheumatoid Disorder, Rheumatology, Anti-inflammatory +9